MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/bco2.70217

Медицинская библиотека · BJUI compass · 2026

Bedside risk score for medical therapy failure in small-volume BPH: Temporal validation.

Alam Numan, Ahmad Naveed, Shirazi Syed Hamzah, Ahmed Aftab, Suria Bilal, Ali Jamshid, Ghazi Muhammad Anas, Shenawa Elham, Khawar Mirza Muhammad Hadeed

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Medical therapy is the first-line treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). However, predictors of treatment failure in men with small prostate volume (<30 ml) remain poorly defined. This study aimed to develop and temporally validate a simple bedside risk score for predicting medical therapy failure in this specific subgroup.

METHODS

We performed a retrospective cohort study of 201 men aged ≥50 years with IPSS ≥8 and prostate volume <30 ml who started medical therapy between 2015 and 2025. Treatment failure was defined as surgical intervention, acute urinary retention or IPSS worsening by ≥4 points. Independent predictors were identified using multivariable logistic regression. A practical integer risk score was derived from the strongest predictors. Temporal validation was conducted by splitting the cohort chronologically (derivation set 2015-2020, n = 120; validation set 2021-2025, n = 81).

RESULTS

During a median follow-up of 24 months, 66 patients (32.8%) experienced treatment failure. Independent predictors included higher IPSS, greater BPH Impact Index, increased intravesical prostatic protrusion, lower maximum flow rate, higher post-void residual volume and diabetes mellitus. The bedside risk score stratified patients into low-risk (0-3 points: 11.0% failure), moderate-risk (4-7 points: 32.9%) and high-risk (8-13 points: 77.5%) categories. The model demonstrated good discrimination (AUC 0.789; bootstrap-corrected 0.782) and maintained strong performance in temporal validation (derivation AUC 0.799; validation AUC 0.821).

CONCLUSION

This novel bedside risk score reliably predicts medical therapy failure in small-volume BPH using readily available clinical parameters. It may enable early risk stratification and timely intervention, particularly in populations with high diabetes prevalence.

Для цитирования: Alam Numan, Ahmad Naveed, Shirazi Syed Hamzah, Ahmed Aftab, Suria Bilal, Ali Jamshid, Ghazi Muhammad Anas, Shenawa Elham, Khawar Mirza Muhammad Hadeed. Bedside risk score for medical therapy failure in small-volume BPH: Temporal validation.. BJUI compass. 2026. DOI: 10.1002/bco2.70217.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.